S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

Aleafia Health Stock Forecast, Price & News

-0.03 (-5.04 %)
(As of 02/26/2021 12:00 AM ET)
Today's Range
Now: $0.57
50-Day Range
MA: $0.65
52-Week Range
Now: $0.57
Volume409,388 shs
Average Volume757,867 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Aleafia Health Inc. operates as an integrated cannabis health and wellness company. It produces a portfolio of products, including dried flower and pre-rolls, as well as oil drops and capsules, and oral sprays. The company offers its products under the Emblem and Symbl brands. It also operates a network of 25 medical cannabis clinics; and education centers. Aleafia Health Inc. is headquartered in Concord, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers—Specialty & Generic
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.00 out of 5 stars

Medical Sector

1921st out of 1,956 stocks

Drug Manufacturers—Specialty & Generic Industry

58th out of 63 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
-0.03 (-5.04 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALEAF News and Ratings via Email

Sign-up to receive the latest news and ratings for ALEAF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Aleafia Health (OTCMKTS:ALEAF) Frequently Asked Questions

What stocks does MarketBeat like better than Aleafia Health?

Wall Street analysts have given Aleafia Health a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Aleafia Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Aleafia Health?

Aleafia Health saw a decline in short interest during the month of January. As of January 29th, there was short interest totaling 186,200 shares, a decline of 47.1% from the January 14th total of 352,100 shares. Based on an average daily volume of 899,400 shares, the days-to-cover ratio is currently 0.2 days.
View Aleafia Health's Short Interest

Who are Aleafia Health's key executives?

Aleafia Health's management team includes the following people:
  • Mr. Geoffrey Benic, Chief Exec. Officer
  • Mr. Benjamin Ferdinand, CFO & Corp. Sec.
  • Mr. Greg Rossi, Chief Operating Officer
  • Dr. Michael Verbora M.B.A., M.D., Chief Medical Officer
  • Mr. Keith White, Pres of Clinic Operations
  • Mr. Nicholas Bergamini, VP of Investor Relations & Public Affairs
  • Mr. Geoff Cowper Smith, Chief Legal Officer & Corp. Sec.
  • Mr. Dave Shepherd, Sr. VP of HR
  • Ms. Patricia Symmes, Chief Commercial Officer

Who are some of Aleafia Health's key competitors?

What is Aleafia Health's stock symbol?

Aleafia Health trades on the OTCMKTS under the ticker symbol "ALEAF."

How do I buy shares of Aleafia Health?

Shares of ALEAF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aleafia Health's stock price today?

One share of ALEAF stock can currently be purchased for approximately $0.57.

How many employees does Aleafia Health have?

Aleafia Health employs 173 workers across the globe.

What is Aleafia Health's official website?

The official website for Aleafia Health is www.aleafiahealth.com.

How can I contact Aleafia Health?

The company can be reached via phone at 416-860-5665.

This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.